Sunder Biomedical Tech. Co., Ltd.
Sunder Biomedical Tech. Co., Ltd. engages in the manufacture and sale of medical devices. It offers endoscopy vision set, suction irrigation set, smoke filter, endo bag, blood line set for hemodialysis, A.V. fistula needle, I.V. administration, volume control I.V. administration, extension tube. surgical tubing set, PVC compounds for medical application, transducer protector, melt blown nonwoven … Read more
Sunder Biomedical Tech. Co., Ltd. (4115) - Total Liabilities
Latest total liabilities as of June 2025: NT$475.51 Million TWD
Based on the latest financial reports, Sunder Biomedical Tech. Co., Ltd. (4115) has total liabilities worth NT$475.51 Million TWD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sunder Biomedical Tech. Co., Ltd. - Total Liabilities Trend (2020–2024)
This chart illustrates how Sunder Biomedical Tech. Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sunder Biomedical Tech. Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Sunder Biomedical Tech. Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Traction Uranium Corp.
OTCQB:TRCTD
|
USA | $69.89K |
|
American Noble Gas Inc.
OTCQB:AMNI
|
USA | $5.95 Million |
|
BC IRON (BC3.SG)
STU:BC3
|
Germany | €216.22 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Sunder Biomedical Tech. Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sunder Biomedical Tech. Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sunder Biomedical Tech. Co., Ltd. (2020–2024)
The table below shows the annual total liabilities of Sunder Biomedical Tech. Co., Ltd. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$540.04 Million | -19.32% |
| 2023-12-31 | NT$669.40 Million | +5.41% |
| 2022-12-31 | NT$635.02 Million | -12.18% |
| 2021-12-31 | NT$723.08 Million | -4.58% |
| 2020-12-31 | NT$757.79 Million | -- |